MTOR and liver dysplastic nodule: Inhibition of adenosine monophosphate-activated protein kinase (AMPK) activity in DN can inhibit the activation of mammalian target of rapamycin (mTOR) and promote cell autophagy to reduce the damage of kidneys [11].